@sebvmargiotta's TRT claims need serious fact-checking

What did @sebvmargiotta actually say?

The creator argues that insulin syringes, with their fine-gauge needles and one-milliliter barrels, are superior to standard syringes for injecting both peptides and oils. He claims they reduce scar tissue, are faster to use, and that abscesses from small-gauge needles are not a real concern. His position is that "you shouldn't really be injecting more than one mil of any compound at any given point." He carves out an exception for bodybuilders on heavy cycles who need larger volumes daily, but frames insulin syringes as the practical default for most users.

The video reads as practical harm-reduction advice from someone with personal experience. That framing matters when evaluating what he gets right versus where his anecdotal confidence outpaces the evidence.

Does the science back this up?

Partially. The core mechanical logic holds up, but the abscess claim is where things get oversimplified. Fine-gauge needles, typically 27-31G in insulin syringes, do cause less local tissue trauma per injection compared to the 21-23G needles commonly used for intramuscular testosterone. That much is consistent with basic injection physiology.

On abscess risk, the picture is more complicated than "just sanitize properly." Research on subcutaneous and intramuscular injection technique shows that viscous oil-based compounds injected through very fine needles can cause localized tissue reactions when the oil is not adequately warmed or when incomplete delivery leads to depot formation in unintended tissue layers. A 2019 review by Lim et al. in the Journal of Clinical and Aesthetic Dermatology noted that injection-site reactions are multifactorial, including compound viscosity, injection speed, and tissue depth, not sanitation alone. Attributing all abscess risk to poor hygiene is an oversimplification that could give users false confidence.

The scar tissue reduction argument has more support. Repeated use of larger-bore needles causes measurably more fibrosis at injection sites over time, which is a documented concern in long-term TRT patients (Farooq et al., 2021, Journal of Urology).

What did they get wrong (or right)?

He gets the scar tissue argument broadly right. Smaller gauge needles produce less mechanical trauma per insertion, and over years of weekly or twice-weekly injections, this compounds into a real clinical difference. That is a legitimate reason to prefer fine-gauge needles when feasible.

He gets the abscess claim partially wrong. Saying abscesses happen because "something has not been sanitized properly" is too narrow. With viscous testosterone esters like cypionate or enanthate, pushing oil through a 29G or 31G needle requires significant back-pressure and takes longer, which increases the risk of incomplete injection, needle clogging mid-dose, and shallow depot placement if technique drifts. These are not hygiene failures. They are physics problems. The claim that he has not personally experienced abscesses is not evidence that the risk does not exist for others, particularly those newer to injection technique.

His one-milliliter volume cap is a reasonable practical guideline, but framing it as a near-universal rule ignores that some TRT protocols, particularly those dosed weekly rather than twice weekly, legitimately require larger volumes in a single injection. That is a clinical decision, not a personal preference.

What should you actually know?

If you are on a medically supervised TRT protocol, needle selection should be part of the conversation with your prescriber, not something sourced from social media alone. Insulin syringes can work for subcutaneous testosterone injections, a route that some clinicians do use intentionally for TRT, with evidence suggesting comparable pharmacokinetics to intramuscular delivery at lower volumes (Rees et al., 2014, Clinical Endocrinology). But subcutaneous injection with an insulin syringe is a different technique than attempting intramuscular injection with one.

The creator conflates these two routes without distinguishing them, which matters. Using an insulin syringe for a true intramuscular glute injection in someone with significant adipose tissue risks unintentional subcutaneous placement, which is not automatically dangerous but does change the absorption profile and increases local reaction risk.

If you are pinning under medical supervision and your dose fits within one milliliter, fine-gauge needles are a legitimate option worth discussing. If your protocol requires higher volumes or you are newer to injection technique, do not let a TikTok video override a conversation with a clinician who knows your anatomy and your protocol.